Health
Newer Type 2 diabetes medications have heart and kidney disease benefits, too – Science Codex
DALLAS, Sept. 28, 2020 — Two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD) and heart disease. Based on analyses of the clinical trials through March 2020, a group of leading experts in diabetes, heart failure, kidney disease and cardiometabolic disease believe the medicines should be considered for people with CKD and Type 2 diabetes to pr…
-
General20 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
General9 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
Noosa News17 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General19 hours agoHomicide Squad investigating ‘suspicious’ death of 84yo woman in Sydney suburb of Melonba